HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bert Vander Cruyssen Selected Research

Ligands

2/2008A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis.
8/2007A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bert Vander Cruyssen Research Topics

Disease

16Rheumatoid Arthritis
01/2022 - 01/2005
3Inflammation (Inflammations)
12/2019 - 02/2008
3Ankylosing Spondylitis
07/2013 - 08/2007
2Osteoarthritis
12/2018 - 06/2012
2Arthritis (Polyarthritis)
12/2012 - 08/2007
2Experimental Arthritis
02/2008 - 08/2007
1Communicable Diseases (Infectious Diseases)
12/2019
1Spondylarthropathies
01/2019
1Pain (Aches)
12/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Joint Diseases (Joint Disease)
03/2017
1Psoriatic Arthritis
06/2012
1Disease Progression
06/2012
1Thrombocytopenia (Thrombopenia)
07/2011
1Necrosis
08/2007

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
01/2022 - 01/2006
5Rheumatoid FactorIBA
01/2022 - 01/2006
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
4Peptides (Polypeptides)IBA
01/2022 - 01/2006
3Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2007
3Antirheumatic Agents (DMARD)IBA
03/2017 - 10/2007
3Methotrexate (Mexate)FDA LinkGeneric
03/2017 - 01/2010
3Infliximab (Remicade)FDA Link
01/2010 - 01/2005
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2019 - 01/2019
2C-Reactive ProteinIBA
03/2017 - 06/2011
2GlucocorticoidsIBA
03/2017 - 04/2015
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2012 - 08/2007
2HLA-B27 Antigen (HLA B27 Antigen)IBA
12/2012 - 06/2011
2LigandsIBA
02/2008 - 08/2007
2EpitopesIBA
10/2007 - 03/2007
1Immunoglobulin A (IgA)IBA
01/2022
1Edetic Acid (EDTA)FDA Link
12/2019
1Etanercept (Enbrel)FDA Link
12/2018
1cyclic citrullinated peptideIBA
01/2018
1Biological ProductsIBA
01/2016
1SteroidsIBA
12/2012
14-hexyloxyaniline (HOA)IBA
06/2012
1Adalimumab (Humira)FDA Link
06/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012
1Heparin (Liquaemin)FDA LinkGeneric
07/2011
1Rituximab (Mabthera)FDA Link
01/2010
1PhytochemicalsIBA
02/2008
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
02/2008
1CytokinesIBA
08/2007
1C-galactosylceramideIBA
08/2007
1alpha-galactosylceramideIBA
08/2007
1Pharmaceutical PreparationsIBA
08/2007
1AntigensIBA
03/2007
1Fibrinogen (Factor I)FDA Link
01/2006
1acetyl 4-aminosalicylic acidIBA
01/2006

Therapy/Procedure

6Therapeutics
06/2011 - 01/2005
3Intravenous Infusions
01/2010 - 01/2005
1Remission Induction
03/2017
1Biological Therapy
01/2016
1Hip Replacement Arthroplasty (Total Hip Replacement)
07/2013
1Retreatment
01/2010